x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

Oprah"s Weight Loss Dilemma: The Ozempic

Inception Point Ai

Join us on "The Oprah Ozempic Odyssey," where we explore the intriguing world of weight loss through the lens of Oprah Winfrey"s recent remarks about the weight loss drug, Ozempic. Dive into the heated debate surrounding the use of weight loss drugs, and discover the pros and cons of Ozempic as we break down its potential benefits and side effects. Through thoughtful discussions and a touch of humor, we help you navigate this complex topic, providing insights and considerations to make informed

health & fitness medicine

All Episodes

2:37

Novo Nordisk CagriSema Outperforms Ozempic in Phase...

Oprah"s Weight Loss Dilemma: The Ozempic ·

2026/02/04

Novo Nordisk's new drug CagriSema has outperformed Ozempic in a recent Phase III trial for type 2 diabetes patients, according to Clinical Trials Arena. In the REIMAGINE 2 study, CagriSema reduced HbA1c levels by 1.91 percentage points and achieved 14.2 percent weight loss after 68 weeks, compared to 1.76 percentage points and 10.2 percent with Ozempic. No weight loss plateau occurred with CagriSema, and 43 percent of patients lost at least 15 percent of their body weight. Martin Holst Lange, Novo

en

2:48

Oprah Endorses GLP-1 Drugs for Weight Loss as...

Oprah"s Weight Loss Dilemma: The Ozempic ·

2026/01/31

Oprah Winfrey has been candid this week about her ongoing use of GLP-1 medications like those containing semaglutide, the active ingredient in Ozempic, for weight management. In recent interviews promoting her new book Enough: Your Health, Your Weight, and What It's Like to be Free, co-authored with Yale professor Dr. Ania M. Jastreboff, she shared that she started these weekly injections in 2023 and views them as a lifelong tool, much like blood pressure medicine. Oprah told People magazine she

en

2:58

GLP-1 Medications Transform Weight Loss Treatment as...

Oprah"s Weight Loss Dilemma: The Ozempic ·

2026/01/28

The landscape of weight loss treatment in America is shifting dramatically as glucagon-like peptide-one receptor agonists, or GLP-1s, continue to dominate conversations about obesity management. According to a Pew Research Center report from January 2026, thirteen states now cover GLP-1s for obesity treatment under Medicaid, though this represents progress tempered by significant setbacks. California, New Hampshire, Pennsylvania, and South Carolina stopped covering these medications as of January

en

2:24

Oprah Reveals Ozempic Weight Regain After Stopping...

Oprah"s Weight Loss Dilemma: The Ozempic ·

2026/01/24

Oprah Winfrey shared striking insights this week on her experience with Ozempic, a popular drug known as semaglutide for type two diabetes and weight management. On the Today Show on January 21, 2026, the media icon revealed she gained 20 pounds after stopping the medication for nearly a year. She wanted to prove she could maintain her weight through discipline alone, including hiking regularly and exercising up to two hours a day, six days a week. But the weight returned quickly, leading her to

en

2:39

Oprah Winfrey Opens Up About GLP-1 Medications for...

Oprah"s Weight Loss Dilemma: The Ozempic ·

2026/01/21

Oprah Winfrey has been candid this week about her experiences with GLP-1 medications like Ozempic for weight loss. According to RadarOnline on January 16, she dropped about 50 pounds two and a half years ago after starting the drug but gained back 20 pounds when she stopped taking it after six months. She shared on The View and her podcast that she once blamed herself for her weight, feeling shame from constant food noise in her head, but now views obesity as a disease beyond personal control, much

en

2:47

Health Canada Approves First Daily GLP One Pill...

Oprah"s Weight Loss Dilemma: The Ozempic ·

2026/01/17

Health Canada approved the first glucagon-like peptide one daily pill, Rybelsus, on Monday for adults with type two diabetes who face high risks of heart disease. This semaglutide pill, made by the same company behind injectable Ozempic and Wegovy, aims to improve blood sugar levels alongside diet and exercise while cutting chances of heart attacks, strokes, or death from cardiovascular events. Company trials with over nine thousand six hundred fifty patients showed it lowered those risks compared

en

2:54

GLP-1 Weight Loss Drugs Cut Grocery Spending 5...

Oprah"s Weight Loss Dilemma: The Ozempic ·

2026/01/14

Recent research from Cornell University reveals that weight-loss drugs like Ozempic and Wegovy are significantly reducing how much Americans spend on food. According to the study published in the Journal of Marketing Research, households cut grocery spending by an average of 5.3 percent within six months of starting these GLP-1 receptor agonist medications, with higher-income families seeing drops over 8 percent. Fast-food and coffee shop spending fell by about 8 percent too. The biggest declines

en

3:13

Ozempic and GLP-1 Medicines Show Promise but...

Oprah"s Weight Loss Dilemma: The Ozempic ·

2026/01/10

Ozempic and similar glucagon like peptide 1 medicines remain at the center of the weight loss conversation this week, as new research and renewed celebrity attention highlight both their promise and their limits. According to a January report from the American Society for Metabolic and Bariatric Surgery, scientists reviewing records from more than fifty thousand patients found that people who had bariatric surgery lost about five times more weight over two years than those using weekly glucagon like

en

3:54

Ozempic Weight Loss Drugs Show Promise but Surgery...

Oprah"s Weight Loss Dilemma: The Ozempic ·

2026/01/08

This week, new research and policy news are reshaping the conversation around Ozempic and other weight loss drugs, while Oprah Winfrey continues to influence how many listeners think about these medications. On the scientific front, a major analysis presented by the American Society for Metabolic and Bariatric Surgery compared real world outcomes for more than fifty thousand people using glucagon like peptide one drugs such as semaglutide, the active ingredient in Ozempic, with those who underwent

en

4:09

Ozempic and Weight Loss: The Transformative Medical...

Oprah"s Weight Loss Dilemma: The Ozempic ·

2025/11/29

The weight loss medication debate has taken a fascinating turn as public figures continue to grapple with the decision to use drugs like Ozempic and Wegovy. Oprah Winfrey, one of America's most influential personalities, has found herself at the center of this conversation, and her stance reveals the complex relationship many people have with these powerful pharmaceutical tools. For years, Oprah publicly resisted using Ozempic, stating that she felt taking the medication would be taking the easy way

en

2:39

Oprah Reveals Ozempic Weight Loss Journey Breaking...

Oprah"s Weight Loss Dilemma: The Ozempic ·

2025/11/26

In the past week, the conversation around weight loss medications, particularly Ozempic, has intensified following new statements from Oprah Winfrey. Oprah recently addressed her own experience with the drug, clarifying her previous comments and responding to public speculation. According to recent reports, Oprah revealed that she lost forty pounds using Ozempic, a medication originally developed for type two diabetes but now widely used off-label for weight loss. Her admission comes after months of

en

5:14

Oprah Breaks Silence on Weight Loss Drugs: Ozempic,...

Oprah"s Weight Loss Dilemma: The Ozempic ·

2025/11/24

Ozempic, the prescription drug originally developed to treat Type 2 diabetes, continues to generate headlines as one of the most discussed weight loss medications on the market. In the past week, the conversation has shifted back into public focus as new studies and high-profile personal stories further drive debate on its use and implications. According to Science Daily, researchers have underscored the impressive impact of GLP-1 drugs such as Ozempic, Wegovy, and Mounjaro on significant weight

en

4:16

Oprah Reveals Weight Loss Drug Strategy Breaking...

Oprah"s Weight Loss Dilemma: The Ozempic ·

2025/11/19

Ozempic continues to dominate weight loss conversations, with its effects and celebrity endorsements fueling public fascination over the past week. Headlines have focused on both the drug’s growing popularity and nuanced statements from influential figures like Oprah Winfrey. The mainstream press has highlighted new comments from Oprah Winfrey regarding her personal experience with weight loss medications. After persistent speculation about her noticeably slimmer appearance at public events such as

en

4:53

Ozempic Breakthrough: Oral Pill, Lower Costs, and...

Oprah"s Weight Loss Dilemma: The Ozempic ·

2025/11/15

In the past week, breakthrough developments surrounding Ozempic and its use for weight loss have dominated health news, reflecting sweeping changes in both medical access and public perception. According to Popular Mechanics, Novo Nordisk, the pharmaceutical giant behind Ozempic and the similar injectable Wegovy, has just revealed the results of a major 71-week clinical study evaluating an oral pill form of semaglutide, the active ingredient in both Ozempic and Wegovy. This study, published in The

en

3:58

Oprah Winfrey Opens Up About Ozempic Weight Loss...

Oprah"s Weight Loss Dilemma: The Ozempic ·

2025/11/08

Ozempic continues to spark headlines as its role in weight loss becomes more central to discussion in both medical circles and popular culture over the past week. Driven by ongoing demand and complex debate, the medication, originally developed for managing type two diabetes, is being increasingly prescribed as an aid for weight reduction. Recent news coverage demonstrates that the public conversation about Ozempic’s impact is not slowing down. One of the most prominent voices weighing in this week

en

2:48

Ozempic Offers Heart Protection Beyond Weight Loss,...

Oprah"s Weight Loss Dilemma: The Ozempic ·

2025/11/01

Recent research has revealed that the heart health benefits of the weight loss drug Ozempic, which contains the active ingredient semaglutide, are not solely due to weight loss. A large study published in The Lancet and led by researchers at University College London analyzed data from more than seventeen thousand adults aged forty five and older who were overweight and had cardiovascular disease. The participants were randomly assigned to receive weekly injections of semaglutide or a placebo. The

en

4:32

Oprah Reveals Weight Loss Journey with Ozempic...

Oprah"s Weight Loss Dilemma: The Ozempic ·

2025/10/29

In the past week, Ozempic and its role in weight loss have remained at the forefront of health news as public discussion deepens about its efficacy, risks, and the pronounced cultural shift these medications have sparked. Ozempic, known generically as semaglutide and originally developed as a diabetes treatment, is a GLP-1 receptor agonist that works by slowing gastric emptying and suppressing appetite, making users feel full longer and reducing overall food intake. This mechanism has made it

en

4:55

Ozempic Revolutionizes Weight Loss: Oprah Leads...

Oprah"s Weight Loss Dilemma: The Ozempic ·

2025/10/18

In the week’s most talked about health news, Ozempic remains front and center as both a weight loss therapy and a social phenomenon. The drug, whose medical name is semaglutide, has been generating headlines after a landmark study published in the October 2025 issue of Value in Health found that broader Medicare access to Ozempic could lead to significant cost savings for the health system alongside notable medical benefits. Researchers from the University of Washington and their collaborators

en

4:52

Ozempic Weight Loss Trend: Oprah Reveals Truth About...

Oprah"s Weight Loss Dilemma: The Ozempic ·

2025/10/11

Ozempic remains at the center of American conversations around weight loss, especially as the demand for prescription medications aimed at shedding pounds continues to surge nationwide. This past week, two topics have dominated news coverage. First, the ongoing popularity and the urgent warnings about counterfeit versions of weight loss drugs like Ozempic. Second, the role that Oprah Winfrey’s public statements are playing in influencing perceptions about what these medications can—and

en

4:17

Ozempic and Weight Loss Revolution: Costco Discounts...

Oprah"s Weight Loss Dilemma: The Ozempic ·

2025/10/08

Ozempic, a once little-known diabetes medication, has dominated health news this week as its widespread use for weight loss continues to reshape conversations and access in the United States. Most recently, major headlines have focused on Costco’s move to make Ozempic and its cousin Wegovy available to members at a significant discount. According to CBS News, as of this week, Costco, in partnership with drugmaker Novo Nordisk, is now selling a one-month supply of Ozempic or Wegovy for four hundred

en

54 results

Similar Podcasts

Доктор Тройняшкин

Доктор Тройняшкин

The Dry Eye Treatment PODCAST

Dry Eye Treatment

Différent et alors ?

PATRICK SULAY

Kyle Kingsbury Podcast

Kyle Kingsbury

The Real Weight Loss Coach

Matty Lansdown